Andrias davidianus Liver-Derived Peptides Ameliorate MASH Accompanied by Attenuation of PPARγ Signaling and Selective Modulation of Gut Microbiota
Metabolites · 28.07.2026 · 16 (8) · 532
DOI: 10.3390/metabo16080532 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolites, online erschienen am 28.07.2026. Verfasst von Xing Shen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, Institute of Future Agriculture, Northwest A&F University, Yangling 712100, China. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Northwest A&F University, Northwest A&F University Start-up Funding, Frontier Interdisciplinary Innovation Team Construction Project in Immunobiology.
Abstract (Originalsprache)
Background
Metabolic dysfunction-associated steatohepatitis (MASH), the progressive stage of metabolic dysfunction-associated steatotic liver disease (MASLD), is characterized by hepatic steatosis, inflammation, and fibrosis, yet no specific therapy has been established. This study evaluated the therapeutic potential of Andrias davidianus liver-derived peptides (ALPs) in a mouse model of MASH.
Methods
ALPs were prepared by enzymatic hydrolysis of fresh Andrias davidianus liver. A MASH model was induced in mice using a methionine- and choline-deficient diet (MRCD). ALP was administered via oral gavage, and its effects were assessed through histological staining (H&E, Oil Red O, and Sirius Red), immunofluorescence (Ki67), apoptosis detection (TUNEL), serum biochemistry, and RNA-sequencing of liver tissues. Gut microbiota composition was also analyzed.
Results
ALP treatment significantly alleviated hepatic histopathological features, including steatosis, inflammation, and fibrosis. It reduced aberrant proliferation and apoptosis of hepatocyte-like cells, and markedly improved serum biochemical markers of liver function. RNA-seq analysis revealed that ALP modulated the expression of lipid metabolism-related genes, an effect associated with suppression of the PPARγ signaling pathway. Furthermore, ALP selectively modulated MRCD-induced gut microbiota dysbiosis, particularly by reducing the Firmicutes-to-Bacteroidota (F/B) ratio and enriching Akkermansia. No overt toxicity was observed in other organs.
Conclusions
Our findings demonstrate that ALP exerts protective effects against MASH by improving lipid metabolism, partially through suppression of the PPARγ signaling pathway, and by selectively modulating specific gut microbial taxa. ALP represents a promising natural therapeutic candidate for MASH.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedicine, Institute of Future Agriculture, Northwest A&F University, Yangling 712100, China.
- College of Animal Science and Technology, Northwest A&F University, Yangling 712100, China.
- State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an 710032, China.
- Tangdu Innovative Institute of Science and Technology, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, China.
ORCID-Profile: Tai An
Förderung
- Northwest A&F University
- Northwest A&F University Start-up Funding
- Frontier Interdisciplinary Innovation Team Construction Project in Immunobiology
Zitieren
APA
Shen, X., Qu, Y. N., Huang, Y. X., Liang, C. Y., Liu, S. J., Liu, N., He, Z. J., Su, S. K., Sun, Q. Z., An, T., & Han, H. (2026). Andrias davidianus Liver-Derived Peptides Ameliorate MASH Accompanied by Attenuation of PPARγ Signaling and Selective Modulation of Gut Microbiota. Metabolites, 16(8), 532. https://doi.org/10.3390/metabo16080532
Vancouver
Shen X, Qu YN, Huang YX, Liang CY, Liu SJ, Liu N, et al. Andrias davidianus Liver-Derived Peptides Ameliorate MASH Accompanied by Attenuation of PPARγ Signaling and Selective Modulation of Gut Microbiota. Metabolites. 2026;16(8):532. doi:10.3390/metabo16080532
BibTeX
@article{Shen2026,
author = {Shen, Xing and Qu, Ya-Na and Huang, Yi-Xiao and Liang, Chen-Yu and Liu, Si-Jia and Liu, Na and He, Zi-Jie and Su, Shuai-Kun and Sun, Qing-Zhu and An, Tai and Han, Hua},
title = {Andrias davidianus Liver-Derived Peptides Ameliorate MASH Accompanied by Attenuation of PPARγ Signaling and Selective Modulation of Gut Microbiota},
journal = {Metabolites},
year = {2026},
volume = {16},
number = {8},
pages = {532},
doi = {10.3390/metabo16080532}
}
EUVIMED